|
---|
Category:Letter
MONTHYEARML24026A2792024-01-31031 January 2024 Framatome - Richland Integrated Inspection Report 07001257/2023004 ML24031A5432024-01-23023 January 2024 Triennial Update to Decommissioning Funding Plan (DFP) for the Framatome Inc., Richland Nuclear Fuel Fabrication Facility Cover Letter ML23352A3912023-12-20020 December 2023 Framatome Inc. - Richland Material Control and Accounting Program Inspection Report 07001257-2023401-Public Cover Letter ML23313A0772023-11-27027 November 2023 Framatome Inc. - Request to Amend License and Approve Criticality Safety Methods - License Amendment 19 (Enterprise Project Identification Number L-2023-LLA-0073) ML23296A0072023-10-25025 October 2023 Framatome-Richland - Core Inspection Report 07001257/2023003 ML23291A2042023-10-18018 October 2023 Framatome Inc., Richland Nuclear Fuel Fabrication Facility'S Request to Amend License No. SNM-1227 and Approval of Criticality Safety Methods ML23255A2892023-09-15015 September 2023 Framatome-Richland Inspection Schedule for Calendar Year 2024 ML23254A2502023-09-13013 September 2023 Request of Additional Information Letter to Framatome ML23202A2022023-07-24024 July 2023 Framatome Richland Core Inspection Report 07001257/2023002 ML23198A3172023-07-17017 July 2023 Framatome Inc. Richland Nuclear Fuel Fabrication Facility'S Revised Chapter 1 of License No. SNM-1227 ML23144A3092023-06-21021 June 2023 Acceptance Letter for Request by Framatome for a License Amendment for an Approval of Criticality Safety Methods ML23144A3372023-06-12012 June 2023 Letter to Framatome Approval of Request to Withhold Proprietary Information ML23145A3082023-06-0202 June 2023 Framatome - Licensing Project Manager Change Letter ML23137A3962023-05-17017 May 2023 Framatome, Inc., Richland Nuclear Fuel Fabrication Facilitys Request to Amend License No. SNM-1227; and Approval of Criticality Safety Methods ML23137A4062023-05-17017 May 2023 Framatome, Inc., Submittal of NRC Form 327s Which Report the Results of Material Balance Accounting and Seid Calculations for the Period March 22, 2022 to March 20, 2023 ML23089A2592023-04-10010 April 2023 2023-001 Framatome-Richland - NRC Integrated Inspection Report 07001257/2023001 ML23089A2602023-03-30030 March 2023 Framatome, Inc. - 2023 Fee Increase for Fuel Cycle Licensees; License No. SNM-1227; Docket No. 70-1257 ML23054A2562023-02-23023 February 2023 60-Day Report to January 2, 2023, Incident Reported Under 10 CFR 70 Appendix a Concurrent Report (NRC Event No. 56292); Framatome Richland Facility; License No. SNWI-1227; Docket No. 70-1257 ML22336A0992023-02-0303 February 2023 Cover Letter - Framatome Proprietary Approval 3x Letter of Intent Submittals 11/21/2022 and 11/29/2022 ML23030B6172023-01-31031 January 2023 Framatome-Richland - Core Inspection Report 07001257/2022004 ML23025A3172023-01-25025 January 2023 Submittal of Integrated Safety Analysis (ISA) Summary Annual Update for Framatome Inc.'S (Framatome'S) Richland, Washington Fuel Fabrication Facility ML22341A1562022-12-0707 December 2022 60-day Follow Up Report for an Incident Reported Under 10 CFR 70 Appendix a (C) Concurrent Report (NRC Event No.56713); Framatome Richland Facility ML22272A0252022-10-0404 October 2022 Framatome-Richland -Integrated Inspection Report 07001257/2022003 ML22263A4652022-09-20020 September 2022 Framatome, Inc. Submittal of Revised Fundamental Nuclear Material Control Plan ML22255A0122022-08-31031 August 2022 Framatome Inc. - Required Reporting of Effluents Per 10 CFR 70.59 ML22238A1602022-08-24024 August 2022 Framatome Richland Facility Emergency Plan Version 16.0 ML22236A5872022-08-23023 August 2022 Framatome Inc., Richland Nuclear Fuel Fabrication Facility'S Intent to Amend License No. SNM-1227; ML22201A5352022-07-21021 July 2022 Framatome 2022-002 Integrated Quarterly Inspection Report ML22192A1272022-07-11011 July 2022 Framatome, Inc., 60-day Report for a May 12, 2022 Incident Reported Under 10 CFR 70 Appendix a 24-hour Report (NRC Event No. 55897) ML22154A4382022-07-11011 July 2022 Cover Letter - Framatome Inc. - Request to Amend License and Approve Criticality Safety Methods - License Amendment 18 (Enterprise Project Identification Number L-2021-LLA-0218) ML22187A1892022-06-29029 June 2022 Framatome-Richland - Inspection Schedule for Calendar Year 2023 ML22187A0392022-06-28028 June 2022 Framatome Documentation Request - 2022-003 PMT ML22137A1282022-06-23023 June 2022 Cover Letter - Framatome- DFP Info and Form 327 Proprietary Review ML22166A3432022-06-10010 June 2022 Framatome Lnc., Submittal of Quality Assurance Program, FS1-0011462, Revision 8.0, 10 CFR 71, Subpart H Quality Assurance Program Description for Packaging and Transportation of Radioactive Materials for Us Fuel ML22132A2292022-05-12012 May 2022 Framatome, Inc., Submittal of NRC Form 327 ML22132A2952022-05-12012 May 2022 Framatome, Inc., Submittal of Triennial Update to Decommissioning Funding Plan (DFP) for the Richland Nuclear Fuel Fabrication Facility ML22087A1212022-03-31031 March 2022 Cover Letter Framatome Inc., - Request for Additional Information Regarding License Amendment Request for Approval of Criticality Safety Methods (Enterprise Project Identification Number L-2021-LLA-0218) ML22059A7582022-03-0303 March 2022 Framatome, Inc., Licensee Performance Review (Nuclear Regulatory Commission Inspection Report 0701257/2022005) ML22060A1262022-03-0101 March 2022 60-day Report to January 4, 2022 Incident Reported Under 10 CFR 70 Appendix a Concurrent Report (NRC Event No. 55686); Framatome Richland Facility; License No. SNM-1227; Docket No. 70-1257 ML22066B2732022-02-28028 February 2022 Framatome, Inc. - Required Reporting of Effluents Per 10 CFR 70.59 for July-December 2021 ML22033A1722022-01-27027 January 2022 Framatome, Inc. Richland Washington Fuel Fabrication Facility Submittal of Update to Integrated Safety Analysis (ISA) ML22025A3902022-01-25025 January 2022 60-day Report to January 4, 2022 Incident Reported Under 10 CFR 70 Appendix a Concurrent Report (NRC Event No. 55686); Framatome Richland Facility ML22024A2152022-01-25025 January 2022 Framatome, Inc. - Richland, U.S. Nuclear Regulatory Commission Integrated Inspection Report 07001257/2021004 ML22024A4832022-01-24024 January 2022 60-Day Report to December 20, 2021 Incident Concurrently Reported Per 10 CFR 70 Appendix A(C) (NRC Event No. 55666); Framatome Richland Facility ML22007A3592022-01-0707 January 2022 Framatome, Inc., 30-Day Report to December 8, 2021 Incident Reported Under 10 CFR 70.50(b)(3) (NRC Event No. 55634) ML21335A3282021-12-23023 December 2021 Response to Framatome Request of 11-1-21 for Withholding Due to Proprietary Information ML21336A7572021-12-0202 December 2021 Framatome, Inc., Richland Facility, 30-day Report to October 12, 2021 Incident Reported Under 10 CFR 70.50(b)(1) (NRC Event No. 55517) 2024-01-31
[Table view] Category:Written Event Report (30 or 60 day)
MONTHYEARML23054A2562023-02-23023 February 2023 60-Day Report to January 2, 2023, Incident Reported Under 10 CFR 70 Appendix a Concurrent Report (NRC Event No. 56292); Framatome Richland Facility; License No. SNWI-1227; Docket No. 70-1257 ML22341A1562022-12-0707 December 2022 60-day Follow Up Report for an Incident Reported Under 10 CFR 70 Appendix a (C) Concurrent Report (NRC Event No.56713); Framatome Richland Facility ML22192A1272022-07-11011 July 2022 Framatome, Inc., 60-day Report for a May 12, 2022 Incident Reported Under 10 CFR 70 Appendix a 24-hour Report (NRC Event No. 55897) ML22060A1262022-03-0101 March 2022 60-day Report to January 4, 2022 Incident Reported Under 10 CFR 70 Appendix a Concurrent Report (NRC Event No. 55686); Framatome Richland Facility; License No. SNM-1227; Docket No. 70-1257 ML22025A3902022-01-25025 January 2022 60-day Report to January 4, 2022 Incident Reported Under 10 CFR 70 Appendix a Concurrent Report (NRC Event No. 55686); Framatome Richland Facility ML22024A4832022-01-24024 January 2022 60-Day Report to December 20, 2021 Incident Concurrently Reported Per 10 CFR 70 Appendix A(C) (NRC Event No. 55666); Framatome Richland Facility ML22007A3592022-01-0707 January 2022 Framatome, Inc., 30-Day Report to December 8, 2021 Incident Reported Under 10 CFR 70.50(b)(3) (NRC Event No. 55634) ML21336A7602021-12-0202 December 2021 Framatome, Inc., Richland Facility, 30-day Report to October 12, 2021 Incident Reported Under 10 CFR 70.50(b)(1) (NRC Event No. 55517) - Redacted 2023-02-23
[Table view] |
Text
framatome January 7, 2022 CJW:22:001 U.S. Nuclear Regulatory Commission Attn: Document Control Desk Director, Office of Nuclear Material Safety and Safeguards 11555 Rockville Pike Washington, D.C. 20555
Subject:
30-Day Report to December 8, 2021 Incident Reported Under 10 CFR 70.50(b)(3) (NRC Event No. 55634); Framatome Richland Facility; License No. SNM-1227; Docket No. 70-1257 On December 9, 2021, the Framatome Richland facility reported to NRC a contaminated individual reporting to a medical facility for evaluation which required a 24-hour report per 10 CFR 70.50(b)(3).
The initial report was made because the event required an unplanned visit to a medical facility by an individual with radioactive contamination on their hands.
This 30-day report is submitted to comply with 10 CFR 70.50(c)(2).
Caller Identification The condition was reported to the NRC Operations Center by Calvin Manning, Framatome Manager of Licensing and Compliance, on December 9, 2021 at 1000 ET.
Mr. Mannings telephone number is (509) 375-8237.
Date, Time, and Exact Location of Incident The reportable condition was created on December 8, 2021 at approximately 0745 PT.
The location was the Scrap Uranium Recovery Facility (SURF) building of Framatomes Richland facility at 2101 Horn Rapids Road, Richland WA 99354.
Incident Description On December 8, 2021 at approximately 0745 an instrument technician was contaminated with uranyl nitrate solution while calibrating process instrumentation. The individual followed safety protocol by utilizing the emergency wash station and as a precaution was sent for medical evaluation due to skin exposure to nitric acid.
Framatome Inc.
2101 Horn Rapids Road Richland, WA 99354 Tel: (509) 375-8100 www.framatome.com 22709WA_P-1 (01/11/2018)
US NRC CJW:22:001 January 7, 2022 Page 2 Prior to leaving the site, Framatome Health and Safety Technicians decontaminated the individual to below release limits with the exception of their hands. The individual's hands were placed inside gloves which were secured to their wrists prior to being transported. The worker was transported to an offsite medical facility accompanied by plant health and safety personnel.
After being evaluated, the individual returned to Framatome where their hands were decontaminated to below release limits and returned to work. The process area where this work was being performed was cleaned and the equipment was secured.
Health and Safety Consequences No medical treatment for skin contamination by acid was necessary. The technician was put on 24 hour2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> urine bioassay and was sent for a whole body scan on December
- 16. Urine bioassay indicated an intake of less than 10.8 microgram and a dose of less than 18.5 mrem. The whole-body scan did not detect any quantity of uranium above background.
External Conditions No significant external conditions were identified.
Status of the Event The event is over and all needed remedial actions are complete.
Notifications to Other Agencies The Washington Department of Health was also notified of the event.
Inclusion in Integrated Safety Analysis The event was identified and evaluated in the Integrated Safety Analysis. Evaluations for exposure to UN solution from a leak or spray are included in E15-01-2.23, Accident Sequence 008-6.
Probable Causes of Event Inadvertent opening of a valve was the cause of the event.
Corrective and Mitigating Actions Mitigating actions included the technicians immediate use of an emergency wash station and prompt medical evaluation.
Corrective actions included decontamination of the technicians skin and the contaminated area.
US NRC CJW:22:001 January 7, 2022 Page 3 Preventive Actions Framatome has undertaken an Apparent Cause Analysis. Preventive actions are in progress and include briefing craft personnel regarding this incident and reviewing required protocols when working on this type of equipment, forming a chemical safety review team to determine if changes to the chemical safety program and practices are warranted, and updating procedures associated with the incident.
If you have questions about this incident or Framatomes response, please contact me by phone at (509) 375-8146.
Sincerely, Colin J. Weber, Flealth Physicist Environmental, Health, Safety and Licensing Cc: U.S. Nuclear Regulatory Commission, Region II Attn: Eric Michel, Chief Fuel Facility Branch 2 Marquis One Tower, 23 T85 245 Peachtree Center Avenue N.E., Suite 1200 Atlanta, GA 30303-8931